researcher comment: the radvax rcc study | hans hammers
Published 4 years ago • 203 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
3:12
researcher comment: the fraction-rcc study | toni choueiri
-
1:27
#kcrs19: hans hammers, m.d., ph.d.
-
3:19
radvax: nivolumab / ipilimumab with sbrt for metastatic renal cell carcinoma
-
1:27
dr. hammers on nivolumab/ipilimumab data in rcc
-
1:17
dr. hammers on the checkmate-214 study for rcc
-
4:53
researcher comment: sitravatinib plus nivolumab in advanced rcc | pavlos msaouel
-
11:17
car-t cells: engineered cancer killers
-
7:41
renal cell carcinoma (rcc) | symptoms causes and treatment | dr vishnu gopal | aster mims kannur
-
3:36
cheese in a kidney disease diet: what cheese maybe ok on a renal diet. should you have cheese w/ ckd
-
4:24
researcher comment: the savoir trial | toni choueiri
-
1:03
dr. hutson discusses the phase iii atlas study in rcc
-
1:21
dr. hammers on the long-term benefits of the checkmate-214 study in rcc
-
5:18
researcher comment: perioperative durvalumab for locally advanced rcc | moshe ornstein
-
2:02
#kcrs20 montage featuring dr. toni choueiri and dr. hans hammers
-
1:37
#kcrs20 "new therapies, better outcome" - dr. hans hammers, utsw
-
1:18
dr. hammers on challenges with car t-cell therapy in rcc
-
3:00
dosing medications for kidney cancer with dr. hans hammers of utsw
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
3:09
dr hans hammers discusses the clinical trial of nivolumab plus ipilimumab in renal cell carcinoma
-
7:11
a conversation with hans hammers, m.d., ph.d
-
4:06
hans hammers kidney cancer patient involvement